These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6243243)

  • 1. Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma.
    Presant CA; Hillinger S; Klahr C
    Cancer; 1980 Jan; 45(1):6-10. PubMed ID: 6243243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphotericin B plus 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC no. 409962) in advanced cancer. Phase I and preliminary phase II results.
    Presant CA; Klahr C; Olander J; Gatewood D
    Cancer; 1976 Nov; 38(5):1917-21. PubMed ID: 991105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCNU-adriamycin therapy in bronchogenic carcinoma.
    Trowbridge RC; Kennedy BJ; Vosika GJ
    Cancer; 1978 May; 41(5):1704-9. PubMed ID: 206337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
    Curtis JE
    Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
    Phillips GL; Fay JW; Herzig GP; Herzig RH; Weiner RS; Wolff SN; Lazarus HM; Karanes C; Ross WE; Kramer BS
    Cancer; 1983 Nov; 52(10):1792-802. PubMed ID: 6354414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC 409462), and cyclophosphamide in refractory adenocarcinoma of the breast and other tumors.
    Presant CA; Kolhouse JF; Klahr C
    Cancer; 1976 Feb; 37(2):620-8. PubMed ID: 1253101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Stolinsky DC; Bull FE; Pajak TF; Bateman JR
    Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphotericin B plus combination chemotherapy for extensive non-small cell bronchogenic carcinoma.
    Sarna G; Lowitz BB; Ganz PA; Cline MJ
    Cancer Chemother Pharmacol; 1980; 5(2):89-92. PubMed ID: 7471319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cyclophosphamide (NSC-26271) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of patients with inoperable or disseminated lung cancer.
    Ahmann DL; Carr DT; Coles DT; Hahn RG
    Cancer Chemother Rep; 1972 Jun; 56(3):401-3. PubMed ID: 19051501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
    Denes AE; Presant CA; Bartolucci A
    Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
    [No Abstract]   [Full Text] [Related]  

  • 11. Amphotericin B induction of sensitivity to adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) plus cyclophosphamide in human neoplasia.
    Presant CA; Klahr C; Santala R
    Ann Intern Med; 1977 Jan; 86(1):47-51. PubMed ID: 264783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adriamycin, BCNU plus cyclophosphamide (ABC) in advanced carcinoma of the head and neck.
    Presant CA; Ratkin G; Klahr C; Brown C
    Cancer; 1979 Nov; 44(5):1571-5. PubMed ID: 227570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group Study.
    Weick JK; Rainey JM; Livingston RB; Baker LH; O'Bryan RM; Chen TT
    Cancer Treat Rep; 1985 Jun; 69(6):583-5. PubMed ID: 2990709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrosourea combinations in lung cancer.
    Livingston RB
    Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy of advanced lung cancer: a randomized trial.
    Hansen HH; Selawry OS; Simon R; Carr DT; van Wyk CE; Tucker RD; Sealy R
    Cancer; 1976 Dec; 38(6):2201-7. PubMed ID: 187312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early pulmonary toxicity after administration of high-dose BCNU.
    Litam JP; Dail DH; Spitzer G; Vellekoop L; Verma DS; Zander AR; Dicke KA
    Cancer Treat Rep; 1981; 65(1-2):39-44. PubMed ID: 6261949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
    Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P
    Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma.
    Presant CA; Van Amburg A; Klahr C
    Cancer; 1977 Sep; 40(3):987-93. PubMed ID: 902247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma.
    DiBella NJ; Nelson RA; Norgard MJ
    Oncology; 1975; 32(2):82-5. PubMed ID: 815858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.